Correlation Between Mednax and BioCryst Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mednax and BioCryst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mednax and BioCryst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mednax Inc and BioCryst Pharmaceuticals, you can compare the effects of market volatilities on Mednax and BioCryst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mednax with a short position of BioCryst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mednax and BioCryst Pharmaceuticals.

Diversification Opportunities for Mednax and BioCryst Pharmaceuticals

MednaxBioCrystDiversified AwayMednaxBioCrystDiversified Away100%
0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Mednax and BioCryst is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Mednax Inc and BioCryst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCryst Pharmaceuticals and Mednax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mednax Inc are associated (or correlated) with BioCryst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCryst Pharmaceuticals has no effect on the direction of Mednax i.e., Mednax and BioCryst Pharmaceuticals go up and down completely randomly.

Pair Corralation between Mednax and BioCryst Pharmaceuticals

Allowing for the 90-day total investment horizon Mednax Inc is expected to generate 1.93 times more return on investment than BioCryst Pharmaceuticals. However, Mednax is 1.93 times more volatile than BioCryst Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. BioCryst Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest  1,398  in Mednax Inc on December 10, 2024 and sell it today you would earn a total of  66.00  from holding Mednax Inc or generate 4.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mednax Inc  vs.  BioCryst Pharmaceuticals

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -1001020
JavaScript chart by amCharts 3.21.15MD BCRX
       Timeline  
Mednax Inc 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mednax Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Mednax is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar1314151617
BioCryst Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioCryst Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BioCryst Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar77.588.599.5

Mednax and BioCryst Pharmaceuticals Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-11.29-8.46-5.62-2.790.022.755.598.4311.2814.12 0.0150.0200.0250.0300.0350.040
JavaScript chart by amCharts 3.21.15MD BCRX
       Returns  

Pair Trading with Mednax and BioCryst Pharmaceuticals

The main advantage of trading using opposite Mednax and BioCryst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mednax position performs unexpectedly, BioCryst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCryst Pharmaceuticals will offset losses from the drop in BioCryst Pharmaceuticals' long position.
The idea behind Mednax Inc and BioCryst Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency